You plan to file a patent application for an invention that uses and/or claims a biological material. Do you need to deposit a sample of the biological material with a recognized depository institution? This article explores the strategic considerations for biological deposits to satisfy the regulations of patent offices in the United States and Europe.
Recent Posts
- Squires Emphasizes AI, Dubs Inherited Backlog ‘An Absolute Dumpster Fire’ and a ‘Betrayal’
- Federal Circuit Clarifies Precedent on Pre-AIA Prior Art ‘By Another’
- Squires Restores PTAB’s RPI Identification Requirement to Exacting Pre-SharkNinja Standard
- Tariffs, Tech Wars, and Patent Turmoil: Navigating IP Strategy in a Rapidly Changing World | IPWatchdog Unleashed
- Life Sciences Masters Panelists Lament Mounting Policy Uncertainty
